Biotechnology - Biotechnology, Men's Health


Current filters:

BiotechnologyMen's Health

Popular Filters

Nymox plunges as NX1207 fails Ph III endpoints


Canada-based biotech firm Nymox Pharmaceutical saw its shares decimated in pre-market trading after it…

BiotechnologyMen's HealthNX1207Nymox PharmaRecordatiResearch

Ampio’s Vyrix unit out-licenses certain rights for Zertane to Paladin


USA-based biotech firm Ampio Pharmaceuticals says its wholly-owned subsidiary Vyrix Pharmaceuticals…

Ampio PharmaceuticalsBiotechnologyEndo Health SolutionsLicensingMen's HealthPaladin LabsVyrix PharmaceuticalsZertane

Amgen's Prolia gets FDA nod for men with osteoporosis


The US Food and Drug Administration last week approved a new indication for world biotech leader Amgen's…

AmgenAnti-Arthritics/RheumaticsBiotechnologyMen's HealthNorth AmericaProliaRegulation

Back to top